rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David C. Hodgson

Director

Company insider

Files Form 4 as: Director, Royalty Pharma; Director and 10% owner, TriNet Group; Director, Alignment Healthcare; Director, DHI Group.

In numbers

Trades disclosed
118
Buys
3
Sells
16
Bought
$11.9M
Sold
$1.2B
Companies
4
Companies where not an officer
4
First trade
23 Jul 2007
Last trade
5 Jun 2026
Last filed
8 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
RPRX Royalty PharmaDirector · Pharmaceuticals · last 5 Jun 20260 buys · 0 sells
TNET TriNet GroupDirector, 10% owner · Professional Services · last 28 May 20261 buy · 8 sells
ALHC Alignment HealthcareDirector · Managed Care & Insurers · last 13 Mar 20260 buys · 0 sells
DHX DHI GroupDirector · Business Services · last 27 Feb 20142 buys · 8 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 8 Jun 2026RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—4,545 at $0.00filing
5 Jun 2026filed 8 Jun 2026RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—4,545 at $0.00filing
28 May 2026filed 1 Jun 2026TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—7,378 at $0.00filing
28 May 2026filed 1 Jun 2026TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—7,378 at $0.00filing
13 Mar 2026filed 17 Mar 2026ALHC Alignment HealthcareManaged Care & InsurersSEC FORM 4 Code A—18,982 at $0.00filing
13 Mar 2026filed 17 Mar 2026ALHC Alignment HealthcareManaged Care & InsurersSEC FORM 4 Code A—18,982 at $0.00filing
23 May 2025filed 28 May 2025TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—4,127 at $0.00filing
13 May 2025filed 14 May 2025RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—7,614 at $0.00filing
13 Mar 2025filed 17 Mar 2025ALHC Alignment HealthcareManaged Care & InsurersSEC FORM 4 Code A—18,710 at $0.00filing
4 Oct 2024filed 8 Oct 2024TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—186 at $0.00filing
7 Jun 2024filed 10 Jun 2024RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—9,293 at $0.00filing
24 May 2024filed 29 May 2024TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—2,930 at $0.00filing
13 Mar 2024filed 15 Mar 2024ALHC Alignment HealthcareManaged Care & InsurersSEC FORM 4 Code A—50,000 at $0.00filing
23 Jun 2023filed 26 Jun 2023RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—7,747 at $0.00filing
3 May 2023filed 5 May 2023TNET TriNet GroupProfessional ServicesSEC FORM 4 Code G—79,891 at $0.00filing
23 Mar 2023filed 27 Mar 2023TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—4,112 at $0.00filing
8 Mar 2023filed 10 Mar 2023ALHC Alignment HealthcareManaged Care & InsurersSEC FORM 4 Code A—36,337 at $0.00filing
8 Jul 2022filed 11 Jul 2022RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—2,346 at $0.00filing
24 Jun 2022filed 24 Jun 2022RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—6,328 at $0.00filing
24 Mar 2022filed 28 Mar 2022TNET TriNet GroupProfessional ServicesSEC FORM 4 Code A—3,148 at $0.00filing

News

DHI Group (NYSE:DHX) Share Price Breaks Above 200-Day Moving Average – Here's What HappenedDHX · dailypolitical.com · 21 Oct 2026Comparing FTI Consulting (NYSE:FCN) and TriNet Group (NYSE:TNET)TNET · themarketsdaily.com · 18 Oct 2026

0 headlines in the last 90 days name David C. Hodgson; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.

Sectors

Industrials19

Buys in green, sells in red, by the company’s sector.

Related people

Hyong KimChief Medical Officer · Chief Medical Officer at Alignment Healthcare, filing Form 4 there in the last year
Marshall UristEVP, Research & Investments · EVP, Research & Investments at Royalty Pharma, filing Form 4 there in the last year
Bonnie L. BasslerDirector · Director at Royalty Pharma, filing Form 4 there in the last year
Christopher HiteEVP & Chairman, Partnering · EVP & Chairman, Partnering at Royalty Pharma, filing Form 4 there in the last year
Joseph S. KonowieckiEVP, Corporate Affairs · EVP, Corporate Affairs at Alignment Healthcare, filing Form 4 there in the last year
Paul Edward ChamberlainDirector · Also traded TNET in the last 90 days
Sidney A. MajalyaSVP, CLO and Secretary · Also traded TNET in the last 90 days
Anthony Shea TreadwaySVP, Chief Revenue Officer · Also traded TNET in the last 90 days